Literature DB >> 8091065

Etiology, biology, and epidemiology of ovarian cancer.

T R Baker1, M S Piver.   

Abstract

Epithelial ovarian cancer kills more women per year than all other gynecologic cancers combined. Pregnancy, oral contraceptive use, and tubal ligation decrease the risk of the disease, whereas risk is increased for women whose family history is consistent with one of the familial ovarian cancer syndromes. Several theories have been postulated concerning the etiology of ovarian cancer, including the incessant ovulation theory and that based on the model of hypergonadotropic hypogonadism. Chromosomal abnormalities and allele losses have been described in ovarian cancers. Involvement of oncogenes and tumor suppressor genes has been investigated as well. Genetic linkage studies are ongoing in families whose history is consistent with one of the familial ovarian cancer syndromes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8091065     DOI: 10.1002/ssu.2980100403

Source DB:  PubMed          Journal:  Semin Surg Oncol        ISSN: 1098-2388


  10 in total

Review 1.  Protein biomarkers of ovarian cancer: the forest and the trees.

Authors:  Brian M Nolen; Anna E Lokshin
Journal:  Future Oncol       Date:  2012-01       Impact factor: 3.404

2.  Epithelial ovarian cancer and exposure to dietary nitrate and nitrite in the NIH-AARP Diet and Health Study.

Authors:  Briseis Aschebrook-Kilfoy; Mary H Ward; Gretchen L Gierach; Arthur Schatzkin; Albert R Hollenbeck; Rashmi Sinha; Amanda J Cross
Journal:  Eur J Cancer Prev       Date:  2012-01       Impact factor: 2.497

3.  Serum endocan levels in endometrial and ovarian cancers.

Authors:  Esra Laloglu; Yakup Kumtepe; Hulya Aksoy; Emsal Pınar Topdagi Yilmaz
Journal:  J Clin Lab Anal       Date:  2016-10-13       Impact factor: 2.352

4.  Development of a multimarker assay for early detection of ovarian cancer.

Authors:  Zoya Yurkovetsky; Steven Skates; Aleksey Lomakin; Brian Nolen; Trenton Pulsipher; Francesmary Modugno; Jeffrey Marks; Andrew Godwin; Elieser Gorelik; Ian Jacobs; Usha Menon; Karen Lu; Donna Badgwell; Robert C Bast; Anna E Lokshin
Journal:  J Clin Oncol       Date:  2010-04-05       Impact factor: 44.544

5.  Incomplete pregnancies and risk of ovarian cancer (Washington, United States).

Authors:  M T Chen; L S Cook; J R Daling; N S Weiss
Journal:  Cancer Causes Control       Date:  1996-07       Impact factor: 2.506

Review 6.  Proteomic contributions to personalized cancer care.

Authors:  John M Koomen; Eric B Haura; Gerold Bepler; Rebecca Sutphen; Elizabeth R Remily-Wood; Kaaron Benson; Mohamad Hussein; Lori A Hazlehurst; Timothy J Yeatman; Lynne T Hildreth; Thomas A Sellers; Paul B Jacobsen; David A Fenstermacher; William S Dalton
Journal:  Mol Cell Proteomics       Date:  2008-07-29       Impact factor: 5.911

7.  Role of eotaxin-1 signaling in ovarian cancer.

Authors:  Vera Levina; Brian M Nolen; Adele M Marrangoni; Peng Cheng; Jeffrey R Marks; Miroslaw J Szczepanski; Marta E Szajnik; Elieser Gorelik; Anna E Lokshin
Journal:  Clin Cancer Res       Date:  2009-04-07       Impact factor: 12.531

Review 8.  Biomarker testing for ovarian cancer: clinical utility of multiplex assays.

Authors:  Brian M Nolen; Anna E Lokshin
Journal:  Mol Diagn Ther       Date:  2013-06       Impact factor: 4.074

Review 9.  Significant effects of mild endogenous hormonal changes in humans: considerations for low-dose testing.

Authors:  F Brucker-Davis; K Thayer; T Colborn
Journal:  Environ Health Perspect       Date:  2001-03       Impact factor: 9.031

10.  Single Gene Prognostic Biomarkers in Ovarian Cancer: A Meta-Analysis.

Authors:  Scooter Willis; Victor M Villalobos; Olivier Gevaert; Mark Abramovitz; Casey Williams; Branimir I Sikic; Brian Leyland-Jones
Journal:  PLoS One       Date:  2016-02-17       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.